Dr Dom D'Agostino | Augmenting Cancer Outcomes: Ketogenic Diets, Caloric Restriction & Hyperbaric Oxygen Therapy

This podcast episode features an in-depth conversation on metabolic therapies and their potential in cancer treatment, particularly focused on glioblastoma and other glycolytic cancers. Our guest, Dr Dom D'Agostino, a researcher and professor with a diverse background in neuroscience, molecular pharmacology, nutrition and physiology, has a particular interest in metabolic therapies. Dr Dom shares how manipulating the body’s metabolism through the glucose ketone index (GKI), therapeutic ketogenic diets, and redox therapies can improve cancer outcomes by reducing tumour growth and enhancing standard treatments like chemotherapy and radiation. We also explore the synergies of non-toxic therapies such as hyperbaric oxygen, metformin, and IV vitamin C, and how these could potentially reduce the side effects and overall outcomes of cancer treatment.We cover:🩺 Standard cancer care with and without metabolic interventions💊 Managing seizures with ketogenic therapies - a superior alternative to anti-seizure drugs🍽 The power of fasting and the importance of protein intake in chemotherapy and cancer augmentation🔥 Why certain cancers are more susceptible to metabolic-based therapies🔬 How overall mitochondrial health dictates cancer cell transformationDom also touches on the fundamental relationship between liver health and cancer growth and metabolic strategies to prevent cancer. If you're interested in the intersection of nutrition and cancer or wondering how far we are from keto becoming part of standard care, this is a must-listen episode.Find Dom:WebsiteMetabolic Health SummitMetabolic Health Summit YouTubeMentioned in this episode:Cancer cases attributable to potentially modifiable risk factorsFasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to ChemotherapyKetones inhibit mitochondrial production of reactive oxygen speciesThe Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong SurvivalKetone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancerMetabolic management of glioblastoma ...with a restricted ketogenic dietClinical trials in progressWant to watch this on video? Subscribe on YouTubeInstagram  @degreesofhealthDisclaimer Hosted on Acast. See acast.com/privacy for more information.

There are no comments yet.

Please log in to write the first comment.